Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06570096
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Premixed vs Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Premixed Versus Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation A Randomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to compare premixed and sequential injections of lidocaine and bupivacaine for supraclavicular brachial plexus block in patients undergoing arteriovenous fistula creation
Detailed Description:
Hemodialysis is the common treatment for end-stage renal disease ESRD condition which improves quality of life and survival rate for this group of patients Arteriovenous fistula AVF creation is the vascular access technique that provides long-term vascular access for hemodialysis patients
Ultrasound-guided supraclavicular brachial plexus block SCBPB is a widely accepted and effective technique for AVF creation procedures It provides analgesia sympathetic blockade optimal surgical conditions and adequate duration of postoperative block that prevents arterial spasm and graft thrombosis It offers higher blood flow in the radial artery and arteriovenous fistula than is achieved with infiltration anesthesia
Lipid-soluble local anesthetics LA such as ropivacaine and bupivacaine are generally more potent and have a significantly longer duration of action as well as a more prolonged onset of action compared to intermediate-potency drugs such as lignocaine mepivacaine and prilocaine A combination of two LAs is often used in regional blocks to utilize the different clinical properties of the drugs to achieve a faster onset and longer block duration
Ultrasound-guided supraclavicular brachial plexus block SCBPB is a widely accepted and effective technique for AVF creation procedures It provides analgesia sympathetic blockade optimal surgical conditions and adequate duration of postoperative block that prevents arterial spasm and graft thrombosis It offers higher blood flow in the radial artery and arteriovenous fistula than is achieved with infiltration anesthesia
Lipid-soluble local anesthetics LA such as ropivacaine and bupivacaine are generally more potent and have a significantly longer duration of action as well as a more prolonged onset of action compared to intermediate-potency drugs such as lignocaine mepivacaine and prilocaine A combination of two LAs is often used in regional blocks to utilize the different clinical properties of the drugs to achieve a faster onset and longer block duration
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None